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Background: Allergic sensitisation has been ascribed to a dysregulated relationship between allergen-specific Th1,
Th2 and regulatory T cells. We hypothesised that the relationship between these T cell subsets could be better
defined using a short-term allergen stimulation system followed by direct analysis of CD154-positive T cells. Using
peripheral blood samples from birch pollinosis patients and healthy non-atopic controls, we sought to explore the
frequencies and phenotype of birch-stimulated CD154-positive T helper cells following ex vivo birch allergen
stimulation.
Results: Activated CD154-positive Th1, Th2 and Tr1-like cells, that co-expressed IFNγ, IL-4 and IL-10 respectively,
were identified in both birch-allergic and non-allergic participants. We observed a close correlation between Th1,
Th2 and Tr1-like cell frequency in non-allergic volunteers, such that the three parameters increased together to
maintain a low Th2: Th1 ratio. The relationship between Th1, Th2 and Tr1-like responses was dysregulated in birch-
allergic patients, with abrogation of the IL-10 response and a higher Th2: Th1 ratio. A close correlation was
observed between Th2 cell frequency and the absolute concentration of birch-specific IgE within the birch-allergic
group, and we confirmed previous reports of a more differentiated T cell phenotype in allergic subjects.
Conclusions: The findings demonstrate an important balance between IFNγ, IL-4 and IL-10 T cell responses to
birch allergen in health, where Th2 responses to allergens were frequently observed, but apparently balanced by
Th1 and regulatory responses. The detection of CD154 positive T cells after short-term antigen stimulation may be a
useful method for the detection of T cell responses to allergens when cost, speed and convenience are priorities.
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Activated Th2 cells play a key role in the initiation and
maintenance of allergic diseases [1]. Over the last decade,
the Th2 paradigm has been refined to stress the import-
ance of balance between Th1, Th2 and regulatory
responses to allergens in determining the outcome [2].
However, much of the literature relates to cultured cell
populations, which may provide only limited information* Correspondence: M.Tarzi@bsms.ac.uk
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reproduction in any medium, provided the orabout the true nature of allergen-specific T cells. More re-
cently, class II tetramer methods have become the reference
method for the ex vivo detection of allergen-specific T cells
[3], but this methodology is restricted to immunodominant
epitopes in subjects with the appropriate HLA-DR haplo-
type; furthermore, co-staining for intracellular cytokine
expression still implies in vitro expansion and/or mitogen
stimulation.
The early activation marker CD154 is transiently
expressed following ligation of the T cell receptor, pro-
viding direct access to an antigen-specific population fol-
lowing ex vivo stimulation [4,5]. The method was showntd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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systems following allergen stimulation [6], and has been
used by Campbell et al. to track T cell responses during
experimental ragweed desensitisation [7]. However, de-
tailed phenotyping of CD154+ T cells after allergen
stimulation has not been reported to date.
We hypothesised that the relationship between Th1,
Th2 and regulatory T cells responding to allergen could
be better defined using this short-term stimulation
system. The objective of this study was to obtain a de-
tailed phenotypic analysis of the allergen-responsive T
cells using a panel of surface markers and intracellular
cytokines, in patients with birch pollinosis compared to
healthy non-atopic control subjects.
Results
CD154+, Th1, Th2 and Tr1-like populations may be
detected after ex vivo birch allergen stimulation
A CD154+ T cell population was detected in both aller-
gic and non-allergic subjects after birch allergen stimula-
tion (Figure 1a, b). Th1 cells were defined as CD154+
IFNγ+ and Th2 cells as CD154+IL-4+ (Figure 1c). In
addition, we detected a CD154+IL-10+ population that
did not express IFNγ or IL-4 in excess of background
signal (Figures 1d, e); for brevity, we refer to this popula-
tion as Tr1-like. The CD154 single-positive response
represented a median of 0.34% and 0.48% of the total
CD4 T cell population in non-allergic and birch-allergic
participants, respectively (p = 0.07, Figure 2).Figure 1 Example of original data in representative non-allergic and
in (a) unstimulated and (b) birch allergen-stimulated PBMC. (c) Identificatio
CD154+IL-10+ T cells did not co-express (d) IFNγ or (e) IL-4. Plots illustrate l
background-corrected cytokine expression.A Th1/ Tr1-like response predominates in birch-tolerant
individuals
In the non-allergic group, the predominant T cell
response to birch allergen comprised of CD154+IFNγ+
Th1 cells (Figure 3a). A significantly higher frequency of
CD154+IL-10+ T cells was also identified in non-allergic
controls compared to birch-allergic individuals (Figure 3b),
although IL-10 was not detected universally. Within the
entire birch-allergic group the median frequency of IL-10+
T helper cells was significantly lower (p = 0.005), but the
distribution was bimodal: fifteen of 23 allergic participants
did not produce detectable IL-10, whereas in 8 subjects
IL-10+ T helper cells were present at a similar frequency
compared to the non-allergic group. Further staining of
the CD154+IL-10+ population was performed in three
representative non-allergic donors: only 23.5% of the
CD154+IL-10+ cells expressed FoxP3 and only 3.5%
were FoxP3+CD25+CD127Low. The IL-10+ T cell popula-
tion was mainly negative for CTLA-4 (7.4%), GITR
(18.7%), TGF-β (9.4%) and granzyme A (3.6%), with higher
expression of granzyme B (21.1%) and perforin (30.4%).
The Th2/ Th1 ratio separates birch-allergic and birch-
tolerant participants better than the frequency of Th2
and Th1 cells
The CD154+IL-4+ Th2 response was greater in birch-
allergic compared to birch-tolerant participants (p < 0.001,
Figure 3c). However, there was considerable overlap be-
tween the groups as the Th2 lymphocyte frequency in thebirch-allergic individuals. Dot plots illustrate CD4+CD154 expression
n of CD154+IFNγ+ Th1 population and CD154+IL-4+ Th2 population.
og fluorescence intensity for all markers. Percentages represent
Figure 2 CD154+ T cells (% of CD4) in non-allergic and
birch-allergic participants.
Figure 3 Birch allergen-induced Th1, Th2 and Tr1-like cell population
(a) CD154+ IFNγ+ cells, (b) CD154+IL-10+ cells and (c) CD154+IL-4+ cells illu
CD4 T cells on a log scale, (d) Th2:Th1 ratio, (e) Th2: Th1 + Tr1 ratio and (f)
birch-allergic individuals
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detected in 53% of the group, but in the remaining 47%,
the frequency of Th2 lymphocytes was similar to the aller-
gic group. By contrast, CD154+IFNγ+ Th1 cells were
detected in most participants and there was no difference
between the groups (Figure 3a).
Despite this overlap, the groups were well-separated
on the basis of the Th2: Th1 ratio, which was signifi-
cantly higher in birch-allergic subjects compared to the
non-atopic population (p < 0.001, Figure 3d). The Th2:
Th1 + Tr1 ratio was also significantly higher in the
birch-allergic group (p < 0.001, Figure 3e).
A close correlation was observed between Th2 cell fre-
quency and the absolute concentration of birch-specific
IgE (analysis restricted to sixteen of 23 birch-allergic
participants (p = 0.03, r = 0.54) (Figure 3f ).
A correlation between Th1, Th2 and Tr1-like responses in
birch-tolerant subjects is dysregulated in birch pollinosis
Amongst non-allergic participants, positive correlations
were noted between the frequency of Th2 cells and the
total CD154 response (p = 0.02, r = 0.54), the Th1 response
(p = 0.02, r = 0.53) and the Tr1-like response (p = 0.004,
r = 0.63) (Figure 4a). Amongst allergic participants, thes in birch-allergic and non-allergic participants. Data represents
strated as the background-corrected frequency of positive cells per 106
correlation of CD154+IL-4+ cell frequency and IgE levels in
Figure 4 Correlations between Th2, Th1 and Tr1-like cell populations in (a) non-allergic and (b) birch-allergic individuals. Data represents
the background-corrected frequency of CD154+IL-4+ Th2 cells, CD154+IFNγ+ Th1 cells and CD154+IL-10+ Tr1-like cells per 106 CD4 T cells.
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weaker and non-significant (p = 0.08, r = 0.37), and
there was no dependence between the frequency of Th2
and Tr1-like lymphocytes (Figure 4b).
T cell responses to control allergens and seasonal
modulation of birch responses support antigen specificity
of the assay
We investigated seasonal changes in T cell responses to
birch pollen allergen between the peak birch pollen season
(April) compared to out of season (August – November)
in a small group of allergic and non-allergic participants.
Amongst non-allergic participants, the Th2: Th1 ratio
was maintained at low levels both in and out of the birch
pollen season (Figure 5a). In contrast, this ratio demon-
strates a marked increase during seasonal exposure in
three birch-allergic subjects (Figure 5b).
In addition, we characterised CD154+ T cell responses
under the same experimental conditions following
PBMC stimulation with allergens to which atopic
patients are not sensitised (Figure 5c). In all cases, the
test antigen (to which the participants have IgE and
clinical symptoms) elicited a high Th2: Th1 ratio as
expected. Following stimulation with a control allergen
(to which the participants have neither IgE nor clinical
symptoms), the Th2: Th1 ratio was low, and similar to
that of the non-allergic control participants.A subgroup of non-atopic IL-4 ‘responders’ maintain a
low Th2: Th1 ratio, whilst a subgroup of allergic IL-10
‘responders’ produce more birch-specific IgG4
To further explore the bimodal distribution of Th2
lymphocyte frequencies in non-atopic participants, we
defined ‘IL-4 responder’ and ‘IL-4 non-responder’ sub-
groups for comparison. The frequency of Th1 and Tr1
cells was significantly greater in the IL-4 responder
group; both groups maintained a similarly low Th2: Th1
ratio (Figure 6a-e). There was no difference in birch
IgG4 concentrations between IL-4 responders and non-
responders (data not shown). By contrast, subgroup ana-
lysis applied to the allergic population with respect to
IL-10 responders/ non-responders demonstrated signifi-
cantly greater levels of birch IgG4 in the IL-10-produ-
cing group (Figure 6f ), but did not demonstrate any
significant differences in the frequency of Th1 or Th2
cells (data not shown). There were no differences in
birch-specific IgE levels between IL10 responder and
non-responder allergic subgroups (data not shown).
Th1 and Th2 cells have a more differentiated phenotype
in allergic participants
We also investigated the phenotype of responding CD154+
and CD154+cytokine+ T cell populations following ex vivo
birch stimulation using the expression of cell surface
markers CD27 and CD45RA. Subsets were defined as naive
Figure 5 Supporting evidence in favour of allergen specificity of the CD154+ T cell assay. Data represents the Th2: Th1 ratio during the
peak birch pollen season (April) and out of season (August – November) in (a) non-allergic and (b) birch-allergic individuals. (c-f) Th2: Th1 ratio
following stimulation with the test allergen (to which the participant has IgE and clinical symptoms) compared to the Th2: Th1 ratio following
stimulation with a control allergen (to which the participant has neither IgE nor clinical symptoms) in four representative participants.
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effector memory (CD45RA-CD27-) and effector memory-like
short-lived “revertant” (CD45RA+CD27-) cells (Figure 7).
Surprisingly, a proportion of CD154+cytokine+ T cells
expressed markers consistent with a naive phenotype.
Further staining in three participants confirmed the co-
expression of CCR7 and CD62L in these cells (data not
shown). In non-allergic participants, the majority of
CD154+ and CD154+cytokine+ T cells were distributed
between the naive and central memory compartments.
By contrast, effector memory Th1 and Th2 cells were
mainly confined to the birch-allergic group.
Discussion
CD154 has been demonstrated to identify an antigen-
specific T cell population following short-term stimula-
tion with pathogen-derived antigens [4,5]. We presenthere the first detailed description of CD154+ T cells
responding to birch allergen in non-atopic control sub-
jects and birch pollinosis patients. Activated Th1, Th2
and Tr1-like lymphocytes were identified in varying pro-
portions in allergic and non-allergic participants, with
considerable overlap between the groups, supporting the
mixed cytokine profile previously described for a num-
ber of allergens [8,9]. However, we demonstrate a novel
relationship between the frequencies of these T cell sub-
sets in birch tolerance, maintaining a low Th2: Th1 ratio
and an appropriate frequency of IL-10+ T cells. This re-
lationship was dysregulated in allergy, with the Th2: Th1
ratio maintained at higher levels and the IL-10 response
abrogated. Our experiments utilised birch allergen
extract antigen rather than Bet v 1, and we have not
performed definitive experiments to demonstrate the
antigen-specificity or functional properties of the T cell
Figure 6 Background-corrected birch-allergen induced cytokine expression in non-allergics (IL4-responders vs. IL4 non-responders).
Data represents (a) CD154+IL-4+, (b) CD154+, (c) CD154+IFNγ+, (d) CD154+IL-10+ illustrated as the frequency of positive cells per 106 CD4 T cells
on a log scale, (e) Th2:Th1 ratio and (f) IgG4 levels in birch-allergic IL-10 responders vs. IL-10 non-responders.
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aspects of the data support specificity for birch pollen,
including: accurate discrimination between allergic and
non-allergic participants on the basis of the Th2: Th1
ratio; a low Th2: Th1 ratio amongst allergic volunteers
following PBMC stimulation with a control allergen to
which they are not sensitised; an increase in the Th2:
Th1 ratio during the birch pollen season amongst aller-
gic participants; a correlation between the Th2 cell
frequency and the concentration of birch-specific IgE.
The birch allergen extract contains a small amount of
LPS, but we have demonstrated that the equivalent con-
centration in PBS does not produce a CD154 or cytokine
response in this assay system (data not shown). A previ-
ous study with CD154/ tetramer co-staining after
prolonged cell culture and re-stimulation questioned the
validity of CD154 as a marker for allergen-specific T
cells [10], but these experimental conditions are known
to invalidate the assay, which is only reliable after short-
term stimulation [6].The close relationship between
Th1, Th2 and Tr1-like cells was first reported by Akdis
et al. [2] using cytokine capture technology. In further
experiments, allergen-specific Th2 responses wereenhanced by inhibiting the function of Tr1 lymphocytes
or increasing Th2 frequency. Our results support the
paradigm that it is the relationship between these T cell
subsets rather than their absolute numbers that may de-
termine B cell class switching to IgE. Furthermore, we
develop the concept by demonstrating a formal correl-
ation between the frequency of Th2 cells and Th1/ Tr1
cells in the non-allergic group. The relationship between
these T cell subsets was dysregulated in the birch allergic
group, with abrogation of the IL-10 response and a
weaker, non-significant correlation between Th2 and
Th1 cell frequency at an increased Th2: Th1 ratio. How-
ever, the concentration of circulating birch IgE corre-
lated closely with the frequency of IL-4 positive T cells
rather than the Th2: Th1 ratio, consistent with the ob-
servations of Crack et al. [11], suggesting that the abso-
lute Th2 lymphocyte frequency represents an important
parameter once sensitisation has occurred.
Interestingly, the Th2 response to birch allergen
amongst non-allergic participants displayed a bimodal
distribution. We observed a significantly higher fre-
quency of Th1 and Tr1-like lymphocytes in the IL-4 ‘re-
sponder’ group, maintaining a low Th2: Th1 + Tr1 ratio,
Figure 7 Phenotypic analysis of birch-stimulated T cell populations based on CD27 and CD45RA cell surface expression. Data represents
the phenotype and representative raw data of (a) CD154, (b) CD154+IFNγ+, (c) CD154+IL-4+ and (d) CD154+ IL-10+ T cells responses in non-
allergic and birch-allergic individuals, expressed as the background-corrected percentage of positive cells of the total responding CD4 T cell
population. CD154+ and CD154 + cytokine + T cell populations were initially calculated using Boolean gating and subsequently analysed for CD27
and/or CD45RA expression.
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face of a Th2 response. Birch-specific IgG4 levels were
similarly low in both groups, although it would be of
interest to repeat this measurement in the birch season.
Platt-Mills et al. described a ‘modified’ Th2 response
characterised by IL-4, IL-10 and the production of cat-
specific IgG4, in a group of cat-tolerant, heavily exposedindividuals [12,13]. Our population was not exposed to
birch pollen and we confirmed that sampling occurred
throughout the year, without clustering after the pollen
seasons. However, it must be noted that the major birch
pollen allergen Bet v 1 belongs to the PR-10 panallergen
family; the T cell response to native birch allergen is
therefore likely to include cells responding to plant-
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than seasonal allergens. The single-epitope detection of
tetramer assays clearly differs markedly in this respect.
Regulatory T cells that secrete IL-10 have a confirmed
role in tolerance induction during natural allergen
exposure [14] and allergen immunotherapy, both con-
ventional [15,16] and experimental [17]. We confirm in
our experiments a higher frequency of IL-10-producing
T cells in non-allergic individuals. The IL-10+ T cells
identified in this assay were predominantly Foxp3-
negative. This is consistent with previous reports of in-
ducible FOXP3-negative, CD4+ T cells of regulatory
function [18,19]. Although we have not demonstrated
the functional suppressive activity of these cells, our
findings are similar to previous reports and support a
role for these cells in natural tolerance [1,2,20].
IL-10 is known to modulate the function of cells
involved in allergic inflammation [21], but the exact
mechanisms by which IL-10-secreting T cells exert their
regulatory function is not entirely clear. The allergen-
specific IL-10-secreting T cells of Akdis et al. [2]
appeared to operate by a mechanism that was dependent
upon PD-1 and CTLA-4 in addition to IL-10. Circulat-
ing IL-10-secreting T cells responding to islet cell anti-
gens have been identified in healthy non-diabetic blood
donors [22], and operate by perforin and granzyme-
mediated killing of antigen presenting cells [23]. It would
be interesting to determine whether environmental aller-
gens are subject to similar regulatory mechanisms given
the moderate expression of these molecules by Tr1-like
cells in our experiments. It is also notable that IL-10
production was bimodally distributed in the allergic
population. The frequencies of Th1 and Th2 cells after
ex vivo birch stimulation were similar between these
groups, but the levels of birch-specific IgG4 were greater
amongst IL-10 responders. The production of allergen-
specific IgG4 is known to be IL-4 and IL-10-dependent
[24], and has attracted intense interest over recent years
for its role in immunotherapy mechanisms [25]. The
clinical significance of our observation is unclear, as the
two allergic subpopulations did not appear to differ in
disease phenotype.
In tetramer studies, allergen-specific T cells were re-
cently described as late-differentiated in subjects allergic
to alder [1] and birch pollen [26], whereas responses to
perennial allergens were early-differentiated in both
allergic and non-allergic subjects [8,9]. Using conven-
tional classification criteria based on surface expression
of CD45RA and CD27, we can confirm that effector
memory Th1 and Th2 cell responses to birch allergen
are predominantly a feature of birch pollinosis, but
responding T cells with an early-differentiated phenotype
were observed at high frequency in both allergic and
non-allergic participants. As discussed, Bet v 1 may havesome characteristics of a perennial allergen in this assay
system, possibly explaining the partial agreement with
tetramer studies. It was interesting to observe that
effector cytokines were readily detected in apparently
naive T cells, supported by co-staining for CD62L and
CCR7. This is unlikely to reflect non-specific staining of
the assay as the frequency is background-corrected
following Boolean gating of cytokine-positive popula-
tions and CD27/CD45RA analysis. Previous reports have
described the ability of naive T cells to acquire memory
characteristics, including up-regulation of activation
markers and/or effector cytokine activity [27]. On this
basis, the apparently naive population may actually
represent a relatively undifferentiated memory popula-
tion, capable of secreting cytokines, but maintaining a
naive-like phenotype [28].
Conclusions
In conclusion, this is the first description of CD154+ T cell
responses to birch allergen in an ex vivo stimulation sys-
tem. We demonstrate a close relationship between Th1,
Th2 and Tr1-like responses to birch allergen in health that
conspires to maintain a low Th2: Th1 ratio. In birch-
allergic individuals, the relationship is dysregulated with a
higher Th2: Th1 ratio, defective Tr1-like responses and
IgE concentration that correlates with the frequency of
Th2 cells. Direct phenotyping of CD154+ T cells after
short-term allergen stimulation may be a useful method
for the investigation of allergen-specific T cells, particu-




This study was approved by the National Research Ethics
Service (South East Coast, Brighton and Hove) and the
University of Sussex Ethics Research Committee. All vol-
unteers provided informed written consent. Birch-allergic
patients (n = 23) with a history of spring rhinitis +/−
pollen food syndrome (n = 18) and a positive skin prick
test to birch pollen allergen extract were recruited
from the Allergy Clinic of the Royal Sussex County
Hospital (Table 1). An age-matched comparison popu-
lation (n = 19) with no history of atopic diseases and nega-
tive skin prick tests to common aeroallergens (birch
pollen, grass pollen mix, early pollinating tree pollen mix,
mid-pollinating tree mix, cat dander) was recruited from
staff and students at Brighton and Sussex Medical School.
The study was approved by the National Research Ethics
Service (South East Coast, Brighton and Hove) and by the
University of Sussex Research Ethics Committee. Blood
samples were taken a minimum of eight weeks outside the
birch pollen season. For the investigation of seasonal vari-
ation in T cell responses to birch allergen, blood samples
Table 1 Participant demographics
Non-allergic Birch-allergic
No. of participants 19 23
Age 30 ± 7 37 ± 15
Sex (M:F) 10:9 5:18
Allergic diseases (%):
Asthma 0 52.2










House dust mite 0 47.8
Moulds 0 4.4
Birch-specific IgE (k/Ul) 0 31.4 ± 29.9
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and again between August and November.Antigens
Birch pollen, grass pollen and cat dander allergen extracts
was a kind gift of Dr Helga Kahlert (AllergoPharma,
Reinbek, Germany). The freeze-dried lyophillisate was
reconstituted with phosphate buffered saline (PBS) to
2×105 protein nitrogen units/ml (PNU/ml) (1330 μg/ml)
and filtered before storage at −20°C. The final LPS
concentration in the stimulation system was estimated
at 1.54 ng/ml by LAL test (Pyrochrome C180,
Pyroquant Diagnostik, Germany). PhytohaemagglutininFigure 8 Assay Optimisation. (a) CD154 expression after birch allergen st
allergic participants. (b) HLA-DR expression illustrated as a percentage of to
representative non-allergic participants.(PHA) (Sigma Aldrich, Dorset, UK) was reconstituted
in PBS to 1 mg/ml before storage at −20°C.
Allergen stimulation
Human peripheral blood mononuclear cells (PBMC) were
isolated from citrated blood by density centrifugation
using Ficoll Paque Plus (GE Healthcare, Buckinghamshire,
UK), washed twice in PBS then resuspended at 5 × 106/ml
in RPMI 1640 (10% FCS, 2 mM L-Glutamine, 1%
Penicillin-Streptomycin). PBMC were then rested for
24 hours at 37°C and 5% humidified CO2 to improve
allergen-induced CD154 expression, possibly relating to
upregulation of CD14+ monocyte MHCII expression
(Figure 8). After resting, 2 × 106 PBMC were stimulated
with allergen at 1000PNU/ ml in a total volume of 500 μl,
in 5 ml polypropylene tubes at 37°C and 5% humidified
CO2 for 2 hours, before the addition of 20 μg/ml Brefeldin
A in 500 μl (10 μg/ml final concentration, Sigma Aldrich,
Dorset, UK) for the final 14 hours. Unstimulated PBMC
served as a negative control for background correction.
10 μg/ml PHA (Sigma Aldrich, Dorset, UK) was used as a
positive control.
Antibody staining
Cells were washed in FACS buffer (PBS, 0.5% BSA, 0.1% so-
dium azide). Surface staining was performed by incubation
for 30 minutes with various combinations of anti-human
CD3-Alexafluor700, CD4-PerCP, CD27-FITC, CCR7-
AlexaFluor647 (BD Pharmingen, Oxford, UK), CD25-APC-
Cy7, CD62L-PacificBlue, CD127-PacificBlue, TGFβ-PeCy7,
GITR-PeCy5 (Biolegend, Cambridge, UK), CD45RA-ECD
(IQ Products, DL Groningen, The Netherlands), CD4-ECD
(Beckman Coulter, High Wycombe, UK), CTLA-4-PE
(eBioscience, Hatfield, UK) and Aqvid dead cell stain
(Invitrogen, Paisley, UK). Cells were then washed in FACS
buffer, fixed and permeabilised (lyse and permeabilisation
II solutions, BD Pharmingen). Intracellular staining was
performed for 30 minutes with various combinations ofimulation in rested vs. unrested PBMC in three representative non-
tal CD14+ monocytes in rested vs. unrested cell populations in five
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CD154-APC-Cy7, CD154-PacificBlue, IL-4-PE, Granzyme
A-PerCP, Granzyme B-Alexafluor647 and Perforin-
PacificBlue and IL-10-APC (Biolegend). For analysis of
FoxP3 expression, cells were additionally permeabilised
using the human FoxP3 buffer set (BD Pharmingen) be-
fore intracellular staining with FoxP3-AlexaFluor488 (BD
Pharmingen). Fluorochrome-conjugated beads were used
for compensation. Fluorescence-minus-one (FMO) con-
trols were performed to ensure the compatibility of fluo-
rochromes and to eliminate antibody effects in cytokine
expression.
Flow cytometric analysis
Cells were washed with FACS buffer prior to acquisition
by LSR II flow cytometer (BD Biosciences, Oxford, UK)
with FACSDiva. A minimum of 4 × 105 CD4 events were
gated for each subject. Aqvid staining demonstrated cell
viability close to 100%, therefore live-dead exclusion was
not routinely performed. Data were analysed using
FlowJO software v9.9.3 (Treestar, Ashland, US). Boolean
gating combinations were computed for cytokine and
cell marker analysis.
Birch-specific IgE and IgG4
Serum samples were frozen at -80°C before batch analysis
for birch IgE and IgG4 concentration, using a Phadia 100
instrument (Thermofisher IDD, Uppsala, Sweden).
Statistical analysis
Statistical analysis was supported by Graphpad Prism
v5.03 (La Jolla, USA). The data distribution was non-
parametric according to the D’Agostino and Pearson
omnibus normality test. Median values were used for
comparison throughout. All cell frequency values were
background-corrected by subtraction of the unstimu-
lated cell frequency from the stimulated cell frequency.
Statistical significance was calculated using the two-
tailed Mann–Whitney U test with a significance level of
0.05. Spearman rank correlation analysis was used to
investigate statistical dependence between variables. To
calculate IL-4: IFNγ ratio, the frequency of CD154+IL-4+
cells was divided by the frequency of CD154+IFNγ+ cells.
Where participants had no detectable CD154+IFNγ+ or
CD154+IL-4+ cells, a value was defined by allocating a
predicted frequency value based on the regression equa-
tion from all responding participants.
Abbreviations
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